1,865
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Does glucose-6-phosphate dehydrogenase deficiency worsen the clinical features of sickle cell disease? A multi-hospital-based cross-sectional study

ORCID Icon, , , , , , , ORCID Icon, & show all

References

  • Tsaras G, Owusu-Ansah A, Boateng FO, et al. Complications associated with sickle cell trait: a brief narrative review. Am J Med. 2009;122(6):507–512.
  • Xu JZ, Thein SL. The carrier state for sickle cell disease is not completely harmless. Haematologica. 2019;104(6):1106–1111.
  • Piel FB, Steinberg MH, Rees DC. Sickle cell disease. N Engl J Med. 2017;376(16):1561–1573.
  • Cappelini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371:64–74.
  • Fasola FA, Fowodu FO, Shokunbi WA, et al. The effect of the coinheritance of glucose-6-phosphate dehydrogenase deficiency on the severity of sickle cell disease. Niger Postgrad Med J. 2019;26(2):118–122.
  • Lewis RA, Kay RW, Hathorn M. Sickle cell disease and glucose-6-phosphate dehydrogase. Acta Haemat. 1966;36:399–411.
  • Gibbs WN, Wardle J, Serjeant GR. Glucose-6-phosphate dehydrogenase deficiency and homozygous sickle cell disease in Jamaica. Br J Haematol. 1980;45(1):73–80.
  • Diop S, Thiam D, Sene A, et al. L’Association drépanocytose-déficit en G-6-PD: prévalence et influence sur le profil évolutif. Médecine D'Afrique Noire. 2000;47(7):322–326.
  • Antwi-Baffour S, Adjei JK, Forson PO, et al. Comorbidity of glucose-6-phosphate dehydrogenase deficiency and sickle cell disease exert significant effect on RBC indices. Anemia. 2019;2019:3179173.
  • Karafin MS, Fu X, D'Alessandro A, et al. The clinical impact of glucose-6-phosphate dehydrogenase deficiency in patients with sickle cell disease. Curr Opin Hematol. 2018;25(6):494–499.
  • Lu YW, Chen TC. Use of trimethoprim-sulfamethoxazole in a patient with G-6-PD deficiency for treating pneumocystis jirovecii pneumonia without haemolysis: case report and literature review. J Clin Pharm Ther. 2020;45(6):1483–1485.
  • Poirot E, Vittinghoff E, Ishengoma D, et al. Risks of hemolysis in glucose-6-phosphate dehydrogenase deficient Infants exposed to chlorproguanil-dapsone, mefloquine and sulfadoxine-pyrimethamine as part of intermittent presumptive treatment of malaria in Infants. PLoS One. 2015 Nov 23;10(11):e0142414.
  • Sansone S, Rottensteiner J, Stocker J, et al. Ciprofloxacin-induced acute haemolytic anaemia in a patient with glucose-6-phosphate dehydrogenase Mediterranean deficiency: a case report. Ann Hematol. 2010;89(9):935–937.
  • Howes RE, Piel FB, Patil AP, et al. G-6-PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2012;9(11):e1001339.
  • Agasa B, Bosunga K, Opara A, et al. Prevalence of sickle cell disease in a northeastern region of the Democratic Republic of Congo: what impact on transfusion policy? Transfus Med. 2010;20(1):62–65.
  • Roper D, Layton M, Rees D, et al. Laboratory diagnosis of G-6-PD deficiency. A British society for haematology guideline. Br J Haematol. 2020;189(1):24–38.
  • Steele C, Sinski A, Asibey J, et al. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test. Am J Hematol. 2019;94(1):39–45.
  • Mbanefo EC, Ahmed AM, Titouna A, et al. Association of glucose-6-phosphate dehydrogenase deficiency and malaria: a systematic review and meta-analysis. Sci Rep. 2017;7:45963.
  • Antwi-Baffour S, Adjei JK, Forson PO, et al. Comorbidity of glucose-6-phosphate dehydrogenase deficiency and sickle cell disease exert significant effect on RBC indices. Anemia. 2019;2019:3179173.
  • Bouanga JC, Mouélé R, Préhu C, et al. Glucose-6-phosphate dehydrogenase deficiency and homozygous sickle cell disease in Congo. Hum Hered. 1998;48(4):192–197.
  • Sagiv E, Fasano RM, Luban NLC, et al. Glucose-6-phosphate-dehydrogenase deficient red blood cell units are associated with decreased posttransfusion red blood cell survival in children with sickle cell disease. Am J Hematol. 2018;93(5):630–634.
  • Benkerrou M, Alberti C, Couque N, et al. Impact of glucose-6-phosphate dehydrogenase deficiency on sickle cell anaemia expression in infancy and early childhood: a prospective study. Br J Haematol. 2013;163(5):646–654.
  • Osho PO, Ojo MD, Osho ES, et al. Impact of glucose-6-phosphate dehydrogenase deficiency on sickle cell anaemia expression: a case report. International Journal of Genetics and Genomics. 2020;8(3):102–105.
  • Igwilo HN, Salawu L, Adeoye Adedeji T. The impact of glucose-6-phosphate dehydrogenase deficiency on the frequency of vasoocclusive crisis in patients with sickle cell anemia. Plasmatology. 2021;15:1–10.
  • Simpore J, Ilboudo D, Damintoti K, et al. Glucose-6-phosphate dehydrogenase deficiency and sickle cell disease in Burkina Faso. Pak J Biol Sci. 2007;10(3):409–414.